|
Phase 1:
One system was chosen and developed into an oxygen rebreather for consumer use called the DAN Remote Emergency Medical Oxygen (REMO2™) system.
DAN sold the REMO2™ system from January 1999 – August 2001. DAN was forced to suspend sales of the REMO2 unit and accessories due to an unexpected loss in the supply of manufactured components.
Phase 2:
Further trials were conducted to develop a new rebreather circuit using FDA approved, off-the-shelf components. Six human trials were conducted to evaluate the production quality of what would become the second generation REMO2 circuit.
Two important enhancements of the second generation circuit were the longer scrubber duration and the reduction in the measured breathing resistance.
DAN began selling the second generation REMO2 and providing training in its use in October of 2003.
For a list of publications related to this study, click here.
|